Published in Neurotherapeutics on July 01, 2012
Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic? Curr Med Chem (2014) 1.02
Neuropeptides as targets for the development of anticonvulsant drugs. Mol Neurobiol (2014) 0.90
Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Front Cell Neurosci (2013) 0.86
The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci (2014) 0.84
GHS-R1a constitutive activity and its physiological relevance. Front Neurosci (2013) 0.81
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus. PLoS One (2013) 0.80
Preclinical evidence of ghrelin as a therapeutic target in epilepsy. Oncotarget (2017) 0.75
Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist. Front Pharmacol (2017) 0.75
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 17.72
Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol (1972) 16.34
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron (2003) 6.05
Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci (2006) 4.25
UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature (2008) 3.91
Serum ghrelin levels are enhanced in patients with epilepsy. Seizure (2006) 2.46
Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov (2011) 2.25
High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist. Mol Endocrinol (2003) 1.97
Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol (2011) 1.85
Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem (2000) 1.84
GABAergic mechanisms in epilepsy. Epilepsia (2001) 1.78
Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods (2007) 1.65
Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun (2002) 1.54
Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest (2006) 1.44
Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia (2012) 1.44
The role of ghrelin in weight gain and growth in epileptic children using valproate. J Child Neurol (2007) 1.42
Global and focal aspects of absence epilepsy: the contribution of genetic models. Neurosci Biobehav Rev (2006) 1.23
Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res (2000) 1.22
Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients. Peptides (2011) 1.17
Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology (2003) 1.17
The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci (2010) 1.17
Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci (2011) 1.13
Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium (2001) 1.08
Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol (2007) 1.07
Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice. Physiol Behav (2010) 1.05
Synaptic plasticity in the human dentate gyrus. J Neurosci (2000) 1.04
Role of ghrelin in the relationship between hyperphagia and accelerated gastric emptying in diabetic mice. Gastroenterology (2008) 1.03
Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol (2002) 1.02
Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat. Epilepsia (2012) 1.01
Mutations affecting GABAergic signaling in seizures and epilepsy. Pflugers Arch (2010) 0.99
Cell biology of the ghrelin receptor. J Neuroendocrinol (2006) 0.99
High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs. J Biol Chem (2011) 0.99
Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology (Berl) (2009) 0.97
Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats. Epilepsy Res (2009) 0.96
Local infusion of ghrelin enhanced hippocampal synaptic plasticity and spatial memory through activation of phosphoinositide 3-kinase in the dentate gyrus of adult rats. Eur J Neurosci (2011) 0.95
Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res (2006) 0.94
Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Endocrinol (2010) 0.93
Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett (2009) 0.91
Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin. Epilepsy Res (2007) 0.91
Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorg Med Chem (2003) 0.90
Ligand-directed signaling: 50 ways to find a lover. Mol Pharmacol (2007) 0.90
Synaptic plasticity in the hippocampal slice preparation. Curr Protoc Neurosci (2011) 0.89
Decreased CREB levels suppress epilepsy. Neurobiol Dis (2011) 0.86
Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides (2007) 0.86
Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem (2009) 0.85
Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res (1989) 0.85
Anticonvulsant neuropeptides as drug leads for neurological diseases. Nat Prod Rep (2011) 0.85
The role of nitric oxide in the inhibitory effect of ghrelin against penicillin-induced epileptiform activity in rat. Neuropeptides (2009) 0.84
Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Neurology (2005) 0.84
Unsaturated fatty acids prevent desensitization of the human growth hormone secretagogue receptor by blocking its internalization. Am J Physiol Endocrinol Metab (2010) 0.84
Attenuation of cyclic AMP production by carbamazepine. J Neurochem (1996) 0.84
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists. J Med Chem (2006) 0.83
Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices. Brain Res (2002) 0.83
The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]I increase induced by ATP and bradykinin in PC12 cells. J Pharmacol Exp Ther (2005) 0.81
Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases. Peptides (2010) 0.79
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus. Eur J Pharmacol (2011) 0.79
Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid. Epilepsia (2009) 0.78
The hepatocarcinoma cell line HepG2 does not express a GHS-R1a-type ghrelin receptor. J Recept Signal Transduct Res (2007) 0.77
Current and potential roles of ghrelin in clinical practice. J Endocrinol Invest (2010) 0.77
The epileptic hippocampus revisited: back to the future. Epilepsy Curr (2007) 0.77
Temporal lobe epilepsy causes selective changes in mu opioid and nociceptin receptor binding and functional coupling to G-proteins in human temporal neocortex. Neurobiol Dis (2009) 0.76
Epileptic focus induced by intrahippocampal cholera toxin in rat: time course and properties in vivo and in vitro. Epilepsy Res (1993) 0.76
Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate. Horm Res Paediatr (2011) 0.76
Inositol trisphosphate (IP3) receptors and epileptic seizure. Jpn J Psychiatry Neurol (1989) 0.76
Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci (2006) 4.10
Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci (2004) 3.61
LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron (2007) 3.17
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A (2002) 3.11
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med (Berl) (2004) 2.68
Focal activities and re-entrant propagations as mechanisms of gastric tachyarrhythmias. Gastroenterology (2008) 2.66
Removal of AMPA receptors (AMPARs) from synapses is preceded by transient endocytosis of extrasynaptic AMPARs. J Neurosci (2004) 2.58
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Regulation of synaptic strength and AMPA receptor subunit composition by PICK1. J Neurosci (2004) 2.19
Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science (2010) 2.11
Origin and propagation of the slow wave in the canine stomach: the outlines of a gastric conduction system. Am J Physiol Gastrointest Liver Physiol (2009) 2.11
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem (2005) 2.03
The Jak/STAT pathway is involved in synaptic plasticity. Neuron (2012) 2.02
Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci (2006) 2.01
Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol Cell Biol (2005) 2.00
Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre synapses by PICK1 and GRIP. Neuron (2003) 1.95
Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci (2002) 1.94
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity. Neuron (2008) 1.82
Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology (2006) 1.77
Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res (2003) 1.75
Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology (2008) 1.70
The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci (2008) 1.68
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure. J Hepatol (2013) 1.68
Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods (2007) 1.65
The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal (2012) 1.64
Hippocalcin functions as a calcium sensor in hippocampal LTD. Neuron (2005) 1.58
Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression. J Neurosci (2006) 1.55
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation (2010) 1.54
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology (2011) 1.53
Interleukin-6, a mental cytokine. Brain Res Rev (2011) 1.53
Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications. Biotechniques (2011) 1.45
Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia (2012) 1.44
Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase. Int J Neuropsychopharmacol (2012) 1.42
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.39
A role for Ca2+ stores in kainate receptor-dependent synaptic facilitation and LTP at mossy fiber synapses in the hippocampus. Neuron (2003) 1.39
Peripheral pacemakers and patterns of slow wave propagation in the canine small intestine in vivo. Can J Physiol Pharmacol (2005) 1.33
PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat Neurosci (2011) 1.28
Expression of NMDA receptor-dependent LTP in the hippocampus: bridging the divide. Mol Brain (2013) 1.28
Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. Int Psychogeriatr (2007) 1.27
The NMDA receptor as a target for cognitive enhancement. Neuropharmacology (2012) 1.24
Metabotropic glutamate receptor-mediated LTD involves two interacting Ca(2+) sensors, NCS-1 and PICK1. Neuron (2008) 1.24
Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.24
Functional maturation of CA1 synapses involves activity-dependent loss of tonic kainate receptor-mediated inhibition of glutamate release. Neuron (2006) 1.24
A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci (2012) 1.23
A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency. J Biol Chem (2002) 1.22
Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke (2009) 1.19
Introduction. Long-term potentiation and structure of the issue. Philos Trans R Soc Lond B Biol Sci (2003) 1.18
Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs. PLoS One (2013) 1.17
Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95. Nat Neurosci (2010) 1.16
Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm (2013) 1.14
Multiple, developmentally regulated expression mechanisms of long-term potentiation at CA1 synapses. J Neurosci (2004) 1.14
Co-activation of p38 mitogen-activated protein kinase and protein tyrosine phosphatase underlies metabotropic glutamate receptor-dependent long-term depression. J Physiol (2008) 1.13
Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci (2011) 1.13
The role of JAK-STAT signaling within the CNS. JAKSTAT (2013) 1.12
Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures. Nat Neurosci (2002) 1.12
Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology (2006) 1.12
Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol (2012) 1.12
A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases. Mol Brain (2009) 1.12
Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology (2004) 1.11
Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression. Nat Neurosci (2002) 1.10
Microtubule-associated protein tau is essential for long-term depression in the hippocampus. Philos Trans R Soc Lond B Biol Sci (2013) 1.10
Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus. J Neurosci (2005) 1.09
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. J Infect Dis (2012) 1.09
Bi-directional modulation of AMPA receptor unitary conductance by synaptic activity. BMC Neurosci (2004) 1.09
A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochem Int (2012) 1.09
Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus. Neuropharmacology (2006) 1.08
NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation. Philos Trans R Soc Lond B Biol Sci (2013) 1.05
Calcium stores and synaptic plasticity. Cell Calcium (2003) 1.05
Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy. Antioxid Redox Signal (2014) 1.05
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients. Virology (2012) 1.05
Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J Neurochem (2003) 1.05
White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab (2012) 1.04
Parallel kinase cascades are involved in the induction of LTP at hippocampal CA1 synapses. Neuropharmacology (2003) 1.04
Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods (2004) 1.03
Mammalian Navigators are microtubule plus-end tracking proteins that can reorganize the cytoskeleton to induce neurite-like extensions. Cell Motil Cytoskeleton (2009) 1.03